SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $339,000 | -16.7% | 8,516 | -16.4% | 0.00% | 0.0% |
| Q3 2017 | $407,000 | -23.5% | 10,190 | -17.4% | 0.00% | -33.3% |
| Q2 2017 | $532,000 | +40.0% | 12,342 | +1.7% | 0.00% | +50.0% |
| Q1 2017 | $380,000 | -22.9% | 12,138 | -38.0% | 0.00% | -33.3% |
| Q4 2016 | $493,000 | +11.3% | 19,570 | +8.9% | 0.00% | 0.0% |
| Q3 2016 | $443,000 | +23.1% | 17,976 | +1.5% | 0.00% | +50.0% |
| Q2 2016 | $360,000 | +42.3% | 17,703 | +6.1% | 0.00% | 0.0% |
| Q1 2016 | $253,000 | – | 16,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |